Objective: We aimed at investigating the association of age-dependent IGF-I SDS with diabetes, dyslipidemia, hypertension, and heart diseases, in a large patient sample. Background: IGF-I has been suggested to be associated with several diseases and a prognostic marker for the development of cardiovascular diseases and risk factors. The findings, though, have been inconsistent possibly due to the methodological factors. Methods: We studied 6773 consecutive primary care patients, aged 18+ years, in a cross-sectional, epidemiological study in primary care, Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment study. All patients underwent a standardized clinical diagnostic and laboratory assessment. IGF-I levels were measured with an automated chemiluminescence assay system. We calculated the odds ratios (OR) for diseases in quintiles of IGF-I, and additionally analyzed the association of age-dependent IGF-I SDS with these conditions. Results: After multiple adjustments for confounders, we found increased ORs for coronary artery disease in patients with high IGF-I. Women, but not men, with low IGF-I also showed increased ORs for coronary artery disease. Dyslipidemia was positively associated with IGF-I. Type 2 diabetes showed a curvilinear association with IGF-I SDS. Conclusions: The findings suggest the existence of multiple and complex interactions between IGF-I and several health conditions. The complex nature of disease- and subgroup-specific associations along with the methodological factors can be held responsible for divergent findings in previous studies.

Einleitung: Ischämische Schlaganfälle ziehen ausgeprägte Entzündungsprozesse im Gehirn sowie Immunreaktionen in der Körperperipherie nach sich, welche den Erkrankungsverlauf und die Regeneration maßgeblich beeinflussen. Die Modulation dieser Immunantwort stellt folglich einen vielversprechenden experimentellen Ansatz in der Schlaganfalltherapie dar. Der ischämische Schlaganfall ist außerdem mit verschiedenen Komorbiditäten und Risikofaktoren assoziiert, deren Auswirkungen auf die komplexen postischämischen pathophysiologischen Prozesse nur in Teilen aufgeklärt sind. So hat eine arterielle Hypertonie (Bluthochdruck) als wichtigster modifizierbarer Risikofaktor durch die Induktion von Gefäßschäden eine zentrale Bedeutung für die Pathogenese von ischämischen Schlaganfällen und geht außerdem mit einer Aktivierung des Immunsystems einher. Der konkrete Einfluss der Hypertonie auf die postischämische Entzündungsreaktion wurde bislang nicht hinreichend untersucht. Die Einbeziehung wichtiger Begleiterkrankungen, wie Bluthochdruck, in die präklinische Schlaganfallforschung gewinnt zunehmend an Bedeutung, da ein erweitertes Verständnis der pathophysiologischen Zusammenhänge auch eine bessere Übertragbarkeit neuer immunmodulatorischer Therapiekonzepte auf den Menschen in Aussicht stellt. Zielstellung: Das Hauptziel dieser Arbeit ist die Identifizierung pathofunktioneller Zusammenhänge zwischen der Immunantwort nach Schlaganfall und manifestem Bluthochdruck. Dafür wurde die zentrale und periphere Entzündungsreaktion nach experimentellem Schlaganfall in einem prämorbiden hypertensiven Tiermodell (spontan-hypertensive Ratte, SHR) im Vergleich mit normotensiven Tieren mithilfe von vorwiegend durchflusszytometrischen, histologischen und molekularbiologischen Methoden analysiert. Daneben sollte das verwendete hypertensive Tiermodell für die Untersuchung immunologischer Aspekte der translationalen Schlaganfallforschung evaluiert werden. Tiere, Material und Methoden: Für alle Tierversuche und Organentnahmen wurden ausschließlich männliche Ratten der Stämme Wistar-Kyoto und SHR im Alter von 12 bis 14 Wochen verwendet. Die Induktion des ischämischen Infarkts erfolgte mithilfe eines permanenten, transkraniellen Schlaganfallmodells oder mittels photochemischer Thrombose. In Abhängigkeit von der Untersuchungsgruppe wurden die Tiere 1 oder 4 Tage nach Infarktinduktion bzw. Sham-Operation schmerzfrei getötet. Neben wenigen neuroanatomischen und neurofunktionellen Ausleseparametern wurde als Hauptzielgröße die Immunzellverteilung im Gehirn und im Blut erfasst. Dafür wurden Hirnzellisolate und Vollblutproben mit maximal 8 fluoreszenzgekoppelten Antikörpern in verschiedenen Kombinationen markiert und in einem 3-Laser-Durchflusszytometer (FACSCanto II) gemessen und ausgewertet. Zudem wurden in kryokonservierten Hirnschnitten relevante Immunzellpopulationen und Adhäsionsmoleküle mittels Immunfluorezenztechniken markiert und für die Darstellung der räumlichen Verteilung mit einem Konfokal-Mikroskop (LSM710, Zeiss) analysiert. Zusätzlich wurde die Gen-und Proteinexpression selektiver Zytokine und Adhäsionsmoleküle in dissoziiertem Hirngewebe ermittelt. Die statistische Auswertung wurde je nach erfasster Zielgröße mittels zweiseitigem t-Test, Wilcoxon Rangsummentest, Pearson-Korrelation oder Varianzanalyse-Verfahren durchgeführt. Ein Signifikanzniveau von p<0,05 wurde für alle statistischen Verfahren festgelegt. Ergebnisse: Neben einer vergrößerten Läsion konnte in hypertensiven Tieren insbesondere eine gesteigerte Infiltration von Zellen des angeborenen Immunsystems in das ischämische Hirn gezeigt werden. Eine Verschiebung des Makrophagen-Granulozyten-Verhältnisses wies darüber hinaus auf eine veränderte Entzündungskinetik bei Vorliegen von Bluthochdruck hin. Weiterhin wurde in Tieren mit arterieller Hypertonie eine erhöhte Zahl von zirkulierenden Monozyten und Granulozyten beobachtet. Im Hirngewebe von spontan-hypertensiven Ratten nach Schlaganfall wurden außerdem eine verminderte Expression des antiinflammatorisch wirksamen Zytokins Interleukin 10, erhöhte Expressionsraten selektiver Leukozyten-rekrutierender Chemokine sowie eine vermehrte Expression des Adhäsionsmoleküls ICAM-1 auf infiltrierenden Leukozyten erfasst. Daneben konnten modellabhängige Einflüsse der verschiedenen Induktionsmethoden auf die Immunreaktion identifiziert werden. Schlussfolgerung: Die Ergebnisse weisen deutlich auf einen Zusammenhang zwischen einem bestehenden arteriellen Hypertonus und einer gesteigerten entzündlichen Reaktion im Gehirn nach experimentellem Schlaganfall hin und zeigen mögliche zugrundeliegende Mechanismen auf. Gleichzeitig unterstreicht die Arbeit durch eine differenzierte Analyse methodischer und modellabhängiger Einflüsse die Unerlässlichkeit, präklinische Ergebnisse kritisch zu hinterfragen und in unterschiedlichen Modellen zu überprüfen. Auf Grundlage der Untersuchungen kann die spontan-hypertensive Ratte zudem als ein für die translationale Schlaganfallforschung geeignetes prämorbides Tiermodell beurteilt werden, in welchem sich der Einfluss des Risikofaktors Bluthochdruck auf die Entwicklung und den Verlauf der postischämischen Entzündung gut abbilden lässt.:Inhaltsverzeichnis Abkürzungsverzeichnis 1 Einleitung 2 Literaturübersicht 2.1 Humaner Schlaganfall - Grundlagen 2.1.1 Epidemiologie und sozioökonomische Bedeutung 2.1.2 Allgemeine Definition und Ätiologie 2.2 Postischämische Entzündung und systemische Immunantwort 2.2.1 Allgemein 2.2.2 Initialer Pathomechanismus der sterilen Entzündung im Gehirn 2.2.3 Immunzellen in der postischämischen Entzündung 2.2.4 Periphere Immunmodulation und postischämische Immunsuppression 2.2.5 Auflösung der Entzündungsreaktion 2.3 Schlaganfall und Hypertonie 2.4 Translation - Schlaganfall im Tiermodell 2.4.1 Tiermodelle 2.4.2 Methoden zur Induktion des experimentellen Schlaganfalls 2.4.3 Translationsproblematik 2.4.4 Die spontan-hypertensive Ratte als prämorbides Tiermodell 2.5 Therapieverfahren und therapeutische Ansätze 3 Zielstellung und Aufbau der Arbeit 4 Publikation 1 5 Publikation 2 6 Zusammenfassende Diskussion 6.1 Infarktvolumina und funktionelle Daten 6.2 Immunzytologie im Hirngewebe 6.3 Immunzytologie im peripheren Blut 6.4 Leukozytenrekrutierung ins ischämische Gewebe 6.5 Fazit, Limitationen und Ausblick 7 Zusammenfassung 8 Summary 9 Literaturverzeichnis Danksagung / Introduction: Ischemic strokes lead to a sequence of immune responses, including pronounced tissue inflammation in the brain as well as distinct reactions of the peripheral immune system that consistently influence disease process and outcome. The modulation of these immune responses therefore represents a promising experimental approach in stroke therapy. Ischemic stroke is also associated with various comorbidities and risk factors whose effects on the complex postischemic pathology have only been partially elucidated. Being the most important modifiable risk factor this especially applies to arterial hypertension that has a central role in the pathogenesis of ischemic stroke by inducing vascular damage but is also associated with a strong activation of the immune system. However, the specific influence of hypertension on postischemic inflammation has not been sufficiently investigated. Besides, the integration of hypertension and other important concomitant diseases is becoming a more regular tool in preclinical stroke modelling in order to expand the understanding of pathophysiological interactions and overcome the translational gap of new immunomodulatory therapies. Aim: The main objective of this work is the identification of pathofunctional interations between the immune response after stroke and preexisting arterial hypertension. For this purpose, the central and peripheral inflammatory response after experimental stroke was investigated in a premorbid hypertensive animal model (spontaneously hypertensive rat, SHR) in comparison with normotensive animals by means of flow cytometric, histological and molecular biological methods. In addition, the hypertensive animal model was supposed to be assessed regarding its suitability for the investigation of immunological aspects in translational stroke research. Material and Methods: For all animal experiments and organ removal, only male rats of the Wistar Kyoto and SHR strains aged 12 to 14 weeks were used. Induction of experimental stroke was performed using either a permanent transcranial stroke model or photochemical thrombosis model. Depending on the study group, animals were killed painlessly 1 or 4 days after infarct induction or sham surgery respectively. In addition to few neuroanatomic and neurofunctional readout parameters, immune cell distribution in the brain and blood was captured as primary variable. Therefore, brain cell isolates and whole blood samples labeled with a maximum of 8 fluorescence-coupled antibodies in different combinations were measured and analyzed in a 3-laser flow cytometer (FACSCanto II). Furthermore, immunofluorescence techniques were applied on cryopreserved brain sections in order to image spatial distribution of relevant immune cell populations and adhesion molecules by means of confocal microscopy (LSM710, Zeiss). In addition, the mRNA and protein expression of selective cytokines and adhesion molecules was determined in dissociated brain tissue. Depending on the targeted parameter statistical analyses were performed by using two-sample t-test, Wilcoxon rank-sum test, Pearson correlation coefficient or analysis of variance. A significance level of p<0.05 was set for all statistical methods. Results: In addition to an enlarged lesion, in hypertensive animals an increased infiltration of cells of the innate immune system to the ischemic brain area was detected. A shift of the macrophage-granulocyte-ratio further indicated an altered inflammatory profile in hypertensive rats. Furthermore, an increased number of circulating monocytes and granulocytes were observed in animals with hypertension. In brain tissue of SHR after stroke, a decreased expression of the anti-inflammatory cytokine interleukin 10 were recorded along with increased expression levels of selective leukocyte-recruiting chemokines and an increased expression of the adhesion molecule ICAM-1 on infiltrating leukocytes. In addition, caused by different induction methods, model-dependent impact on the immune reaction could be identified. Conclusion: The results clearly indicate a relationship between existing arterial hypertension and an increased inflammatory response in the brain after experimental stroke and point out potential underlying mechanisms. At the same time, by adopting a differentiated view of methodological and model-dependent influences, the work underscores the need for critical reflection and constant verification of preclinical results in different models. Finally the work validates the SHR strain as a suitable premorbid preclinical system for further translational research since it well models the influence of hypertension on the development and course of postischemic inflammation.:Inhaltsverzeichnis Abkürzungsverzeichnis 1 Einleitung 2 Literaturübersicht 2.1 Humaner Schlaganfall - Grundlagen 2.1.1 Epidemiologie und sozioökonomische Bedeutung 2.1.2 Allgemeine Definition und Ätiologie 2.2 Postischämische Entzündung und systemische Immunantwort 2.2.1 Allgemein 2.2.2 Initialer Pathomechanismus der sterilen Entzündung im Gehirn 2.2.3 Immunzellen in der postischämischen Entzündung 2.2.4 Periphere Immunmodulation und postischämische Immunsuppression 2.2.5 Auflösung der Entzündungsreaktion 2.3 Schlaganfall und Hypertonie 2.4 Translation - Schlaganfall im Tiermodell 2.4.1 Tiermodelle 2.4.2 Methoden zur Induktion des experimentellen Schlaganfalls 2.4.3 Translationsproblematik 2.4.4 Die spontan-hypertensive Ratte als prämorbides Tiermodell 2.5 Therapieverfahren und therapeutische Ansätze 3 Zielstellung und Aufbau der Arbeit 4 Publikation 1 5 Publikation 2 6 Zusammenfassende Diskussion 6.1 Infarktvolumina und funktionelle Daten 6.2 Immunzytologie im Hirngewebe 6.3 Immunzytologie im peripheren Blut 6.4 Leukozytenrekrutierung ins ischämische Gewebe 6.5 Fazit, Limitationen und Ausblick 7 Zusammenfassung 8 Summary 9 Literaturverzeichnis Danksagung

Summary: Salivary alpha-amylase: More than an enzyme - Investigating confounders of stress-induced and basal amylase activity (Dipl.-Psych. Jana Strahler) The hypothalamus-pituitary-adrenal (HPA) axis and the autonomic nervous system (ANS) are two of the major systems playing a role in the adaptation of organisms to developmental changes that threaten homeostasis. The HPA system involves the secretion of glucocorticoids, including cortisol, into the circulatory system. Numerous studies have been published that introduced salivary cortisol to assess HPA axis activity and therefore strengthens its role as an easy obtainable biomarker in stress research that can be monitored easily and frequently. Recent findings suggest a possible surrogate marker of autonomic activity due to autonomic innervation of salivary glands: salivary alpha-amylase (sAA). Up to date, additional methodological research is needed for a better understanding of the advantages and disadvantages of sAA activity in comparison to already established markers of ANS activity. The aim of the present thesis is to further our knowledge of confounders of sAA activity under basal and acute stress conditions and to strengthen the validity of this enzyme as an easy obtainable alternative for ANS testing. After introducing classical and modern stress concepts and stress system physiology (chapter 2), the reader is acquainted with anatomical basics of salivary gland innervation and secretion of salivary proteins, including sAA, due to autonomic innervation (chapter 3 and 4). Afterwards, a more nuanced review of methodological considerations of sAA determination shows gaps of knowledge concerning its usefulness as a marker of ANS activity (chapter 5). Given the fact that the integration of sAA into developmental and aging research is a relative recent phenomenon, several issues have to be addressed before a final conclusion could be drawn. Therefore, we conducted a series of studies incorporating these considerations regarding behavioral correlates of inter- and intraindividual differences in sAA activity with a special emphasis on older adults. Chapter 7 deals with sAA activity under psychological stress conditions in different age groups. Since vulnerability to disease and disease prevalence patterns change with age, it is important to investigate stress reactivity of people in different age groups. We therefore investigated children between 6 and 10 years, because childhood is a sensitive period of growth and development, and thus plays an important role for later life health. Young adults were included to represent the most studied human age group as a reference. Older adults between 59 and 61 years were investigated, because at this age the course is set for the further development of a person’s health in later life, and because autonomic stress responses in older age might be important determinants of cardiovascular and inflammatory aging. Our goal is to test for associations of sAA with more established stress system markers, i.e., salivary cortisol as outcome measurement of HPA reactivity, heart rate (HR) and heart rate variability (HRV) as markers for autonomic reactivity, and to directly compare these responses between different age groups across the life span. Secretion of sAA and cortisol was repeatedly assessed in 62 children, 78 young adults, and 74 older adults after exposure to a standardized psychosocial stressor, the Trier Social Stress Test. In addition, cardiovascular activity was measured in both adult groups. Older adults showed attenuated sAA, HR, and HRV responses. Furthermore, we found higher sAA but lower cortisol at baseline as well as lower sAA and cortisol responses in children. Age by sex interactions were observed only for cortisol with higher responses in older male participants. No associations between the parameters were found. Results in children and young adults confirm previous results. Overall, findings implicate sAA as an alternative or additional autonomic stress marker throughout the life span, with marked and rapid responsiveness to stress in three relevant age groups. The impact of age and chronic stress on basal sAA activity is the center of interest in chapter 8. We therefore assessed diurnal profiles of sAA and salivary cortisol in 27 younger and 31 older competitive ballroom dancers as well as 26 younger and 33 older age- and sex-matched controls. According to the Allostatic Load concept, repeated, non-habituating responses to social-evaluative conditions, which characterize the lives of competitive ballroom dancers, should be associated with stress system dysregulations. Furthermore, we expect to see an increased sympathetic drive associated higher overall alpha-amylase activity in older adults. Analyses revealed an elevated daily overall output of sAA in older adults while there was no effect of age on mean cortisol levels. Alterations of diurnal rhythms were only seen in younger male dancers showing a flattened diurnal profile of sAA and younger dancers and female older dancers showing a blunted diurnal rhythmicity of cortisol. Furthermore, we found a negative correlation between summary indices of basal sAA and the amount of physical activity. In conclusion, higher overall output of sAA in older adults was in line with the phenomenon of a “sympathetic overdrive” with increasing age. Furthermore, a lower output of sAA in people who are more physical active was in line with the hypothesis of an exercise-induced decrease of sympathetic activity. Taken together, results of chapter 7 and 8 show a clear impact of age on sAA activity, either under acute stress or basal conditions. One problem when integrating sAA into developmental and aging research is the use of adrenergic agonists and antagonists what is very common in older adults, i.e. antihypertensive drugs (AD). As well, the previously shown sympathetic overactivity that occurs with normal aging is associated with higher blood pressure (BP). Therefore, chapter 9 deals with a possible impact of high BP and AD on diurnal sAA activity in 79 older adults (33 normotensive adults, 16 medicated vs. 45 hypertensive adults, 34 medicated). Results showed a pronounced rhythm of sAA in all groups. Diurnal profiles differed significantly between men and women with men lacking the typical decrease of sAA in the morning and showing more pronounced alterations throughout the day. An effect of AD on sAA profiles and area under the curve values indicates that subjects not using AD´s show a heightened diurnal profile and a higher total output of sAA. Descriptively, this was also true for hypertensive older adults. Hypertensive subjects and those not using AD showed the highest diurnal output of sAA and the steepest slope. In sum, our results show an impact of antihypertensive medication and a difference between normotensive and hypertensive subjects on characteristics of diurnal sAA activity. Hence, findings are of particular interest in research using sAA as a prognostic indicator of pathological states and processes. Given the fact that hypertension was also shown to be associated with substantial changes of transmitters within the suprachiasmatic nucleus (SCN) - the “biological clock” that receives photic input from retinal glands via the retinohypothalamic pathway - and an altered output from the SCN to the sympathetic nervous system, we broaden the idea of a possible effect of different lighting conditions on morning sAA profiles in chapter 10. In a counterbalanced within-subjects design six men and 16 women of different ages collected sAA morning profiles on two consecutive days with leaving their shutters closed on the one day (= dark) and open their shutters on the other day (= bright). We were able to replicate earlier findings of light-induced changes of salivary cortisol with higher responses during the bright condition. On either day, women showed larger cortisol increases than men. Despite multisynaptic autonomic connections arising from the SCN projecting to multiple organs of the body, we could not find an effect of sunlight on sAA morning profiles. Evidence for circadian clock gene expression in human oral mucosa might account for this result and indicates that peripheral oscillators may act more like integrators of multiple different time cues, e.g. light, food intake, instead of a “master” oscillator (SCN). Results of chapter 7 to 10 provide clear evidence that sAA is heightened in states of autonomic arousal, i.e. stress, aging and hypertension, and that its circadian rhythmicity seems to be regulated rather integrative than directly via efferent input from hypothalamic SCN neurons. In chapter 11 this thesis tries to approach one central question: What is the biological meaning of the findings made? According to this enzyme´s anti-bacterial and digestive action short term changes might not have a biological meaning itself but rather reflect just a small part of multiple coordinated body responses to stressful stimuli. While the sympathetic branch of the ANS mainly stimulates protein secretion, the parasympathetic branch stimulates saliva flow. Acute stress responses might therefore be interpreted as reflecting predominant sympathetic activity together with parasympathetic withdrawal. The same mechanism could also be suitable for the finding of higher diurnal levels of sAA in older adults or hypertensive subjects reflecting a higher peripheral sympathetic tone in these groups. Diurnal profiles of sAA itself may reflect circadian changes in autonomic balance. Circadian rhythms are of great advantage since they enable individuals to anticipate. This pre-adaptation enables the individual to cope with upcoming demands and challenges. Our finding of a relationship between sAA and salivary cortisol what strengthens the relevance of glucocorticoids that were previously shown to be able to phase shift circadian rhythms in cells and tissue. Within a food-related context there is evidence that decreasing levels of sAA in the morning could reflect increases of feeling hungry since sAA systematically increases during food consumption and with the subjective state of satiety. So far, much more research is needed to identify underlying physiological mechanisms of circadian sAA rhythmicity. Taking the next step, future studies will have to focus on the integration of sAA assessment into longitudinal studies and different disease states to prove its applicability as a marker of sympathetic neural functioning in the genesis and prognosis of disease.:Table of Contents 1. Introduction 1 2. Stress 3 2.1. Stress concepts 3 2.1.1. Traditional concepts of stress 3 2.1.2. Allostasis and Allostatic Load 4 2.2. Stress system physiology 6 2.2.1. The hypothalamic-pituitary-adrenal (HPA) axis 6 2.2.1.1. Physiology 6 2.2.1.2. HPA axis activity indicators 6 2.2.2. The autonomic nervous system (ANS) 7 2.2.2.1. Physiology 7 2.2.2.2. ANS activity indicators 8 2.2.3. Relationships between stress systems 10 3. Saliva and salivary glands 11 3.1. Physiology 11 3.1.1. Anatomy, origin, and composition 11 3.1.2. Innervation 12 3.1.3. Salivary gland physiology with aging 13 3.2. Saliva and salivary flow 13 3.3. Protein secretion 14 4. Alpha-amylase in saliva 15 4.1. Chemical characteristics 15 4.2. Secretion of alpha-amylase 15 4.3. Diagnostic value of alpha-amylase 16 5. Methodological considerations of alpha-amylase determination 17 5.1. Collection methods and preparation 17 5.1.1. Saliva collection 17 5.1.2. Impact of flow rate 17 5.1.3. Impact of pH-value 18 5.2. Biochemical determination 18 5.3. Interindividual differences in sAA activity 19 5.3.1. Basal activity 20 5.3.2. Acute responses 20 5.3.3. Age effects 21 5.3.3.1. Basal amylase activity 21 5.3.3.2. Stress-induced amylase activity 21 5.3.4. Sex differences 22 5.3.4.1. Basal amylase activity 22 5.3.4.2. Stress-induced amylase activity 23 5.3.5. Modulating factors influencing amylase (re-)activity 24 5.3.5.1. Impact of smoking 24 5.3.5.2. Impact of alcohol 25 5.3.5.3. Impact of caffeine 25 5.3.5.4. Impact of high body fat and obesity 26 5.3.5.5. Impact of food intake 26 5.3.5.6. Impact of physical exercise 27 5.3.5.7. Impact of somatic and psychiatric diseases 27 5.3.5.8. Impact of medical drugs 29 5.3.5.9. Impact of sunlight on diurnal amylase 29 6. Aims and outline of the present work 31 7. Salivary alpha-amylase stress reactivity across different age groups 32 7.1. Introduction 32 7.2. Methods 35 7.2.1. Participants 35 7.2.2. Study Protocol 35 7.2.3. Measures 36 7.2.3.1. Saliva sampling 36 7.2.3.2. Heart rate and heart rate variability 36 7.2.3.3. Biochemical analyses 37 7.2.3.4. Psychometrical analyses 37 7.2.4. Statistical analyses 38 7.3. Results 38 7.3.1. Sample characteristic 38 7.3.2. Subjective stress response 39 7.3.3. Physiological stress response 39 7.3.3.1. Salivary alpha-amylase 39 7.3.3.2. Salivary cortisol 40 7.3.3.3. Heart rate 42 7.3.3.4. Heart rate variability 43 7.3.3.5. Determinants of the salivary alpha-amylase stress response 45 7.4. Discussion 45 7.5. Conclusion 48 8. Aging diurnal rhythms and chronic stress: Distinct alteration of diurnal rhythmicity of salivary alpha-amylase and cortisol 49 8.1. Introduction 49 8.2. Methods 52 8.2.1. Participants 52 8.2.2. Study protocol 53 8.2.3. Measures 53 8.2.3.1. Saliva sampling 53 8.2.3.2. Biochemical parameters 54 8.2.3.3. Psychological parameters 54 8.2.4. Statistical analyses 54 8.2.4.1. Preliminary analyses 54 8.2.4.2. Diurnal course of salivary alpha-amylase 55 8.3. Results 56 8.3.1. Sample characteristic 56 8.3.2. Preliminary analyses: impact of oral contraceptives, blood pressure, and lipid lowering medication on diurnal profiles 56 8.3.3. Diurnal course of salivary alpha-amylase 57 8.3.3.1. Salivary alpha-amylase over the day 57 8.3.3.2. Salivary alpha-amylase after awakening 58 8.3.4. Diurnal course of salivary cortisol 59 8.3.4.1. Salivary cortisol over the day 59 8.3.4.2. Salivary cortisol after awakening 60 8.3.5. Diurnal course of salivary biomarkers: associations and determinants 61 8.4. Discussion 62 8.5. Conclusion 65 9. Impact of blood pressure and antihypertensive drugs on diurnal alpha-amylase activity: A novel marker of sympathetic drive 67 9.1. Introduction 67 9.2. Methods 68 9.2.1. Participants 68 9.2.2. Study protocol 69 9.2.3. Measures 69 9.2.3.1. Saliva sampling 69 9.2.3.2. Biochemical parameters 69 9.2.3.3. Blood pressure assessment 70 9.2.4. Statistical analyses 70 9.3. Results 70 9.3.1. Participants 70 9.3.2. Salivary alpha-amylase 71 9.3.2.1. Salivary alpha-amylase over the day 71 9.3.2.2. Salivary alpha-amylase after awakening 74 9.4. Discussion 75 9.5. Perspectives 76 10. Light affects morning salivary cortisol, but not salivary alpha-amylase 77 10.1. Introduction 77 10.2 Methods 79 10.2.1. Participants 79 10.2.2. Study protocol 80 10.2.3. Measures 80 10.2.3.1. Saliva sampling 80 10.2.3.2. Biochemical parameters 81 10.2.4. Statistical analyses 81 10.3. Results 82 10.3.1. Sociodemographics 82 10.3.2. Salivary alpha-amylase 82 10.3.3. Salivary cortisol 84 10.3.4. Associations between biochemical parameters 85 10.4. Discussion 86 10.5. Conclusion 89 11. General discussion 90 11.1. Summary of the results 90 11.1.1. Salivary alpha-amylase stress reactivity across different age groups 91 11.1.2. Aging diurnal rhythms and chronic stress: Distinct alteration of diurnal rhythmicity of salivary alpha-amylase and cortisol 91 11.1.3. Impact of blood pressure and antihypertensive drugs on diurnal alpha-amylase activity: A novel marker of sympathetic drive 92 11.1.4. Light affects salivary morning cortisol, but not salivary alpha-amylase 93 11.2. Integration of main findings 93 11.3. Stress-induced amylase activity, basal rhythm, and its biological meaning 95 11.4. Methodological consequences 97 11.4.1. Circadian variation 97 11.4.2. Longitudinal variation 98 11.4.3. Short-term variation and stability 98 11.4.4. Long-term change 99 11.5. Outlook 100 12. References 102